Search For "drugs controller"
CBI arrests DCGI official in Rs 4 lakh bribery case
Updated : 3 years, 9 months ago IST
New Delhi [India], June 21 (ANI): The Central Bureau of Investigation (CBI) on Tuesday arrested one Drug Controller General of India (DCGI) official in the national capital for allegedly taking a bribe of Rs 4 lakh.
Read More
Bharat Biotech's COVID-19 nasal vaccine phase III trials completed
Updated : 3 years, 9 months ago IST
Paris [France], June 19 (ANI): Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech on Saturday (local time) said that the clinical phase III trials of the COVID-19 nasal vaccine have been completed and the company will submit its data with Drugs Controller General of India (DCG
Read More
Bharat Biotech seeks DCGI's permission to conduct Covaxin booster trials i
Updated : 3 years, 10 months ago IST
New Delhi [India], May 4 (ANI): Hyderabad-based pharma company Bharat Biotech has sought permission from the Drugs Controller General of India (DCGI) to conduct trials of Covaxin as COVID-19 vaccine booster dose in the 2-18 age group, sources said.
Read More
NTAGI to review data of COVID-19 vaccines for children aged 5-12 years: So
Updated : 3 years, 10 months ago IST
New Delhi [India], May 2 (ANI): The COVID-19 working group of the National Technical Advisory Group on Immunisation (NTAGI) will review the data of COVID-19 vaccines for the children aged 5 to 12 years on May 4, said sources on Monday.
Read More
SEC seeks more data from Serum Institute over COVID vaccine Covovax for 7-
Updated : 3 years, 11 months ago IST
New Delhi [India], April 30 (ANI): The Drugs Controller General of India's (DCGI) subject expert committee on Friday sought more data from Pune based Serum Institute of India (SII) on the Covovax vaccine for the age group of 7-12 years.
Read More
Paediatricians welcome COVID vaccines for kids, say parents mustn't hesita
Updated : 3 years, 11 months ago IST
New Delhi [India], April 26 (ANI): The Drugs Controller General of India (DCGI) on Tuesday granted an emergency use authorisation (EUA) to Bharat Biotech's Covaxin for the age group of 6-12 years.
Read More
DCGI approves COVID-19 vaccine Covaxin for children aged 6-12
Updated : 3 years, 11 months ago IST
Hyderabad (Telangana) [India], April 26 (ANI): The Drugs Controller General of India (DCGI) on Tuesday granted an emergency use authorisation (EUA) to Bharat Biotech's Covaxin for the age group of 6-12 years.
Read More
Corbevax COVID-19 vaccine gets DCGI's nod for children aged 5-12
Updated : 3 years, 11 months ago IST
Hyderabad (Telangana) [India], April 26 (ANI): The Drugs Controller General of India (DCGI) granted emergency use authorisation to Biological E's COVID-19 vaccine Corbevax for those aged 5 to 12 years, informed the pharmaceutical company on Tuesday.
Read More
DCGI grants EUA to ZycovD COVID vaccine for two-dose regimen for children
Updated : 3 years, 11 months ago IST
Ahmedabad (Gujarat) [India], April 26 (ANI): The Drugs Controller General of India (DCGI) on Tuesday granted Emergency Use Authorisation (EUA) to Zydus Cadila vaccine (ZycovD) for COVID-19 as a two-dose vaccine for children above the age of 12 years, said Zydus Lifesciences Ltd., the phar
Read More
DCGI gives emergency use authorisation to Covaxin for 6-12 age group
Updated : 3 years, 11 months ago IST
New Delhi [India], April 26 (ANI): The Drugs Controller General of India (DCGI) gives restricted emergency use authorisation to Covaxin for the 6-12 age group.
Read More
Bharat Biotech to rectify issues raised by WHO on Covaxin soon: Sources
Updated : 3 years, 11 months ago IST
New Delhi [India], April 4 (ANI): Hyderabad-based pharmaceutical company, Bharat Biotech will rectify the issues raised by the World Health Organization regarding its COVID-19 vaccine-- Covaxin-- in a few days and added that the company has informed about this development to the Drugs Con
Read More
Phase 2,3 trial data of India's first mRNA COVID vaccine submitted to DCGI
Updated : 4 years ago IST
New Delhi [India], March 18 (ANI): Pune-based Gennova Biopharmaceuticals has submitted the phase-II and phase-III trials data of India's first mRNA COVID vaccine to the regulator Drugs Controller General of India (DCGI) on Friday, said sources.
Read More